Triad Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Buy
5,553
+1,564
+39% +$126K 0.03% 320
2026
Q1
$346K Sell
3,989
-488
-11% -$46.8K 0.03% 361
2025
Q4
$430K Buy
4,477
+1,076
+32% +$105K 0.04% 296
2025
Q3
$324K Buy
3,401
+628
+23% +$57.7K 0.04% 272
2025
Q2
$242K Sell
2,773
-362
-12% -$30.7K 0.05% 250
2025
Q1
$282K Buy
3,135
+362
+13% +$32.4K 0.09% 172
2024
Q4
$221K Buy
+2,773
New +$240K 0.08% 166
2024
Q3
Sell
-2,290
Closed -$180K 555
2024
Q2
$180K Buy
+2,290
New +$188K 0.09% 103

Other funds holding MDT

Triad Wealth Partners's MDT Position: Q2 2026 in Review

Triad Wealth Partners increased its Medtronic (MDT) stake by 39% in Q2 2026, buying an estimated $126K and bringing the position to 5,553 shares worth $481K. The position accounts for 0.03% of the portfolio, ranked #320.

Triad Wealth Partners first reported a position in MDT in Q2 2024 and has held it in 8 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Triad Wealth Partners held 5,553 shares of Medtronic worth $481K as of Q2 2026.
  • Triad Wealth Partners bought 1,564 Medtronic shares in Q2 2026, an estimated $126K.
  • Medtronic made up 0.03% of Triad Wealth Partners's portfolio in Q2 2026, its #320 holding.
  • Triad Wealth Partners first reported a position in Medtronic in Q2 2024 and has held it in 8 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Triad Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.